04 August 2021>: Animal Study
Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway
Jun Ding 1ABCDEFG** , Chuang Qi 2BCDEF* , Jinmao Li 1BCDF , Chuying Huang 2BCD , Jiayao Zhang 1BCF , Yong Zhang 1BC , Yi Li 1BCF , Bin Fan 1CFDOI: 10.12659/MSM.929255
Med Sci Monit 2021; 27:e929255
Figure 4 Se-methylselenocysteine (MSC) treatments improved liver functions by modulating levels of (A) total bilirubin, (B) alkaline phosphatase, (C) γ-glutamyl transpeptidase, and (D) albumin in serum of rats in different groups. ## P<0.01 vs Normal control group. * P<0.05 and ** P<0.01 vs Model group.